awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33275887-F0C19C0D-8020-4191-AC18-A47B6B21AA95
Q33275887-F0C19C0D-8020-4191-AC18-A47B6B21AA95
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33275887-F0C19C0D-8020-4191-AC18-A47B6B21AA95
Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors.
P2860
Q33275887-F0C19C0D-8020-4191-AC18-A47B6B21AA95
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33275887-F0C19C0D-8020-4191-AC18-A47B6B21AA95
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
363ba674c827d21344f1d2be13f31dc8bef2ba88
P2860
A phase I/II study of erlotinib in combination with the anti-insulin-like growth factor-1 receptor monoclonal antibody IMC-A12 (cixutumumab) in patients with advanced non-small cell lung cancer